Japan's Vaccine Service and an Introduction to the History of Cumulative Vaccine Coverage

During the measles epidemic periods in 1999-2003, a research group elaborated a method of estimating vaccination coverage. The objective of cumulative vaccination coverage (CVC) was to estimate the age of vaccine completion for vaccine targets in an age cohort. From randomly selected children of an age cohort, vaccine records including the date of birth and date of vaccine administration were retrieved, allowing for the calculation of the age of vaccine targets. By acquiring this information, it is possible to derive vaccination trends by age. According to the literature, CVC is now more widely applied and is used for monitoring delays of vaccination due to changes of the vaccine administration schedule and schedule interaction when newly-introduced vaccines are implemented. Although CVC is rather costly because it requires random sampling, we conclude that it is a useful method for estimating herd immunity.

[1]  Kenzo Takahashi,et al.  Japan's Vaccine Service and an Introduction to the History of Cumulative Vaccine Coverage , 2013 .

[2]  J. Kobayashi,et al.  The relevance of Japan's hepatitis vaccine policy to national Hepatitis B prevention and control , 2012, Journal of public health policy.

[3]  Yasushi Ohkusa,et al.  The economic disease burden of measles in Japan and a benefit cost analysis of vaccination, a retrospective study , 2011, BMC health services research.

[4]  F. Temel,et al.  Lot quality survey: an appealing method for rapid evaluation of vaccine coverage in developing countries – experience in Turkey , 2008, BMC Public Health.

[5]  Progress toward measles elimination--Japan, 1999-2008. , 2008, MMWR. Morbidity and mortality weekly report.

[6]  Toshiko Yamamoto,et al.  Historical review of BCG vaccine in Japan. , 2007, Japanese journal of infectious diseases.

[7]  N. Okabe.  Amendment of the Infectious Diseases Control Law , 2004 .

[8]  H. Gomi,et al.  Why is measles still endemic in Japan? , 2004, The Lancet.

[9]  C. Murray,et al.  Validity of reported vaccination coverage in 45 countries , 2003, The Lancet.

[10]  K. Shiraki.  Perinatal transmission of hepatitis B virus and its prevention , 2000, Journal of gastroenterology and hepatology.

[11]  N. Guérin.  Assessing immunization coverage: how and why? , 1998, Vaccine.

[12]  M. Anker,et al.  The lot quality technique: a global review of applications in the assessment of health services and disease surveillance. , 1997, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.